论文部分内容阅读
目的从文献计量学角度分析国内外联合用药治疗鲍曼不动杆菌(Ab)感染相关文献,旨在为临床治疗鲍曼不动杆菌感染提供参考。方法检索Pubmed、Embase、Cbmdisc中联合用药治疗Ab的相关文献,截止时间为2013年1月。用Endnote 2.0软件进行分类整理,对文献的发表年份、作者、发表期刊、研究机构、文章类型等进行分析。结果共纳入991篇文献,其中英文965篇,中文26篇。第1篇报道在1975年,2011年达到高峰,为111篇。目前超过20个国家或地区有撰文报道。希腊的美国生物科学学会是发文最多的机构,河北医科大学第二医院发文量居国内第一位。文献类型主要为综述,其次为研究性论文及回顾性分析,也有小部分的病例分析。结论国际上对于联合用药治疗Ab的相关研究重点有从基础研究向临床应用转化的趋势;国内联合用药研究比国外研究晚,但紧追国外步伐。
OBJECTIVE: To analyze the literature about the treatment of Acinetobacter baumannii (Ab) infection both at home and abroad with reference to biodometrics, aiming to provide reference for clinical treatment of Acinetobacter baumannii infection. Methods PubMed, Embase and Cbmdisc were used to search the related articles of Ab for the treatment of Ab. The deadline was January 2013. Endnote 2.0 software for sorting, the publication of the literature, authors, published journals, research institutes, article types and other analysis. Results A total of 991 articles were included, including 965 in English and 26 in Chinese. The first report reached its peak in 1975 and 2011, reaching 111. There are currently more than 20 countries or regions have written reports. The American Society for Biological Sciences in Greece is the largest organization with the largest number of texts. The No. 2 Hospital of Hebei Medical University publishes the largest volume in the country. The main types of literature review, followed by research papers and retrospective analysis, but also a small part of the case analysis. Conclusion The international research on the combination therapy of Ab has focused on the transformation from basic research to clinical application. The domestic combination study is later than foreign studies, but it is closely followed by foreign countries.